Tumor-infiltrating Cytotoxic T Lymphocytes as Independent Prognostic Factor in Epithelial Ovarian Cancer With Wilms Tumor Protein 1 Overexpression-Reference-Cited by-同舟云学术

Tumor-infiltrating Cytotoxic T Lymphocytes as Independent Prognostic Factor in Epithelial Ovarian Cancer With Wilms Tumor Protein 1 Overexpression

Published:2011-07 Issue:6 Volume:34 Page:516-523
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Vermeij Renee,de Bock Geertruida H.,Leffers Ninke,ten Hoor Klaske A.,Schulze Ute,Hollema Harry,van der Burg Sjoerd H.,van der Zee Ate G.J.,Daemen Toos,Nijman Hans W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference1 articles.

1. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.;Kobel;PLoS Med,2008

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer;Journal for ImmunoTherapy of Cancer;2023-11

2. Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer;Cancers;2022-05-06

3. Tumor-infiltrating Lymphocytes as Markers of the Antitumor Therapy Efficacy: Myth or Reality?;Interdisciplinary Cancer Research;2022

4. Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer;Cancer Immunology, Immunotherapy;2020-08-27

5. Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome;OncoImmunology;2020-01-01